FDA Approves Dupilumab Label Expansion with Indication for CRSwNP in Adolescents

Retrieved on: 2024-09-13 19:54:11

Tags for this article:

Otorhinolaryngology

Rhinology

Regeneron Pharmaceuticals

Polyp

Nasal cavity

Click the tags to see associated articles and topics

FDA Approves Dupilumab Label Expansion with Indication for CRSwNP in Adolescents. View article details on hiswai:

Excerpt

Pfizer continues to explore broadening use of the RSV immunization and has initiated a clinical trial evaluating RSVPreF in children aged 2 to younger ...

Article found on: www.patientcareonline.com

View Original Article